EGFR and triple-negative breast carcinoma: Furthermore, it would be expected to sensitize tumors to induction of apoptosis by cytotoxic agents and, perhaps, in combination with EGFR inhibitors in triple-negative breast cancer and with drugs such as rapamycin that cause the feedback activation of PI3K/Akt signaling [38].